Market breadth is weakening as the advance-decline line diverges from major indexes, hinting at fragility beneath the surface and raising concerns that an AI-driven consumer boom could be fueling an unsustainable rally.

Policy tailwinds and precision medicine breakthroughs are pushing healthcare stocks like Tempus AI and CRISPR Therapeutics into a new era of growth.

The Canadian Dollar (CAD) extends its decline against the US Dollar (USD) on Thursday, with USD/CAD climbing above the 1.4000 psychological mark to reach its highest level since April 10.

China further tightened restrictions on exporting rare earths, which are vital components in a range of consumer and military items.

The FTSE 100 in London pulled back on Thursday after hitting a record high in the previous session.